Commodore Capital »

Helix Acquisition Corp Ii Cl A shares owned by Commodore Capital

Quarter-by-quarter ownership of Helix Acquisition Corp Ii Cl A (HLXB) shares owned by Commodore Capital from 13F filings

Historical chart of Commodore Capital investment in Helix Acquisition Corp Ii Cl A

Tip: Access up to 7 years of quarterly data

All positions including Helix Acquisition Corp Ii Cl A held by Commodore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Helix Acquisition Corp Ii Cl A by Commodore Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.1M 500k 10.22
2024-03-31 $5.2M 500k 10.40

More positions owned by Commodore Capital

Merus N V (MRUS)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Vaxcyte (PCVX)
Enliven Therapeutics (ELVN)
Vera Therapeutics Cl A (VERA)
Cogent Biosciences (COGT)
Soleno Therapeutics (SLNO)
Celldex Therapeutics Com New (CLDX)
Mind Medicine Mindmed Com New (MNMD)
Rhythm Pharmaceuticals (RYTM)
Arvinas Ord (ARVN)
Spyre Therapeutics Com New (SYRE)
Perspective Therapeutics Com New (CATX)
Pharvaris N V (PHVS)

View all positions for Commodore Capital

Top funds holding Helix Acquisition Corp Ii Cl A

Cormorant Asset Management
BlackRock
Citadel Advisors
T. Rowe Price Associates
Millennium Management
OZ Management
Farallon Capital Management
Dr. Jeffrey R. Jay, M.D.
Perceptive Advisors
Silverarc Capital Management
Commodore Capital
Soros Fund Management
T. Rowe Price Investment Management
Ghost Tree Capital
Laurion Capital Management

View all funds holding Helix Acquisition Corp Ii Cl A